Recently, many people have learned about semaglutides and the good they're doing for diabetes and obesity. Medications like Ozempic, Wegovy, Mounjaro, and Rybelsus have received widespread attention, ...

A systematic review of 52,501 participants found that 45.3% of type 2 diabetes patients have micronutrient deficiencies, with ...

Diabetes and heart health are influenced by A1C, body weight, cardiovascular health, and the duration of diabetes. Excess ...

A lack of essential micronutrients, such as vitamin D and magnesium, as well as a few others, may be behind 'hidden hunger' ...

Defining the Diabetes Disease Process and Treatment Options Insulin resistance and its role in gestational diabetes mellitus (GDM) should be defined for the patient. GDM should be differentiated ...

New Delhi: Sun Pharma Labs has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug ...

A new study conducted by researchers from Charles University (Prague, Czech Republic) has uncovered a significant LINK between obstructive sleep apnea syndrome and increased mortality among ...

Corcept Therapeutics Incorporated’s CORT share price has surged by 13.60%, which has investors questioning if this is right time to sell.

South Korea: A study of over 1.9 million patients with type 2 diabetes (T2D) found that glomerular hyperfiltration (GHF) was ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Ascendis Pharma boasts several commercial stage products. Read why ASND stock is an interesting speculative investment ...